Screener
Mirum Pharmaceuticals, Inc. MIRM Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s interest expense?
- Mirum Pharmaceuticals, Inc. (MIRM) reported interest expense of $2.62M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s interest expense changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s interest expense decreased by 27.1% year-over-year, from $3.59M to $2.62M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s interest expense?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s interest expense has grown at a -3.4% compound annual growth rate (CAGR), from $15.98M to $14.39M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Mirum Pharmaceuticals, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude